Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol

This publication has 29 references indexed in Scilit:

• Prostaglandins: A new approach to glaucoma management with a new, intriguing side effect
  Survey of Ophthalmology, 1997
• Prostaglandin-induced iridial pigmentation in primates
  Survey of Ophthalmology, 1997
• A 90-Day Study of the Efficacy and Side Effects of 0.25% and 0.5% Apraclonidine vs 0.5% Timolol
  Archives of Ophthalmology (1950), 1996
• Around-the-Clock Intraocular Pressure Reduction With Once-Daily Application of Latanoprost by Itself or in Combination With Timolol
  Archives of Ophthalmology (1950), 1996
• Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents
  The Lancet, 1995
• Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol.
  British Journal of Ophthalmology, 1995
• Additive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressure.
  British Journal of Ophthalmology, 1994
• The potential of ??2-adrenergic agonists in the medical treatment of glaucoma
  Current Opinion in Opthalmology, 1994
• The Effects on Aqueous Dynamics of PhXA41, a New Prostaglandin F2α Analogue, After Topical Application in Normal and Ocular Hypertensive Human Eyes
  Archives of Ophthalmology (1950), 1993
• Comparison of Apraclonidine and Timolol in Chronic Open-angle Glaucoma
  Ophthalmology, 1993